Microbiología clínica y enfermedades Infecciosas

Marcos-Zambrano, LJ; Gomez, A; Sanchez-Carrillo, C; Bouza, E; Munoz, P; Escribano, P; Guinea, J.

Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(12): Nº de citas: 14 [doi:10.1016/j.cmi.2018.07.006]

Marin, M; Ruiz, A; Iglesias, C; Quiroga, L; Cercenado, E; Martin-Rabadan, P; Bouza, E; Rodriguez-Sanchez, B.

Identification of Nocardia species from clinical isolates using MALDI-TOF mass spectrometry

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(12): Nº de citas: 40 [doi:10.1016/j.cmi.2018.06.014]

Zamora-Cintas, M; Marin, M; Quiroga, L; Martinez, A; Fernandez-Chico, MA; Bouza, E; Rodriguez-Sanchez, B; Alcala, L.

Identification of Porphyromonas isolates from clinical origin using MALDI-TOF Mass Spectrometry

ANAEROBE. 2018; 54: 197-200 Nº de citas: 6 [doi:10.1016/j.anaerobe.2018.06.017]

Perez-Granda, MJ; Alonso, B; Rodriguez-Huerta, A; Rodriguez, C; Guembe, M.

In vitro assessment of the anti-biofilm activity of ethanol alone and in combination with enoxaparin 60 IU

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2018; 36(10): 627-632 Nº de citas: 1 [doi:10.1016/j.eimc.2017.11.007]

Acosta, F; Perez-Lago, L; Serrano, MJR; Marin, M; Kohl, TA; Lozano, N; Niemann, S; Valerio, M; Olmedo, M; Perez-Granda, MJ; Perez, MR; Bouza, E; Munoz, P; de Viedma, DG.

Fast update of undetected Mycobacterium chimaera infections to reveal unsuspected cases

Journal of Hospital Infection. 2018; 100(4): 451-455 Nº de citas: 6 [doi:10.1016/j.jhin.2018.08.018]

Dandachi, D; Dib, RW; Fernandez-Cruz, A; Jiang, Y; Chaftari, AM; Hachem, R; Raad, I.

Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes

ANNALS OF MEDICINE. 2018; 50(8): 713-720 Nº de citas: 27 [doi:10.1080/07853890.2018.1518581]

Arendrup, MC; Meletiadis, J; Zaragoza, O; Jorgensen, KM; Marcos-Zambrano, LJ; Kanioura, L; Cuenca-Estrella, M; Mouton, JW; Guinea, J.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(11): 1200-1204 Nº de citas: 39 [doi:10.1016/j.cmi.2018.02.021]

Kumar, D; Ferreira, VH; Blumberg, E; Silveira, F; Cordero, E; Perez-Romero, P; Aydillo, T; Danziger-Isakov, L; Limaye, AP; Carratala, J; Munoz, P; Montejo, M; Lopez-Medrano, F; Farinas, MC; Gavalda, J; Moreno, A; Levi, M; Fortun, J; Torre-Cisneros, J; Englund, JA; Natori, Y; Husain, S; Reid, G; Sharma, TS; Humar, A.

A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients

CLINICAL INFECTIOUS DISEASES. 2018; 67(9): 1322-1329 Nº de citas: 147 [doi:10.1093/cid/ciy294]

Vehreschild, MJGT; Taori, S; Goldenberg, SD; Thalhammer, F; Bouza, E; van Oene, J; Wetherill, G; Georgopali, A.

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(11): 2097-2106 Nº de citas: 18 [doi:10.1007/s10096-018-3344-1]

ALONSO FERNANDEZ, BEATRIZ; PEREZ GRANDA, MARIA JESUS; RODRÍGUEZ HUERTA, ANA MARÍA; RODRÍGUEZ GONZÁLEZ, CARMEN GUADALUPE; BOUZA SANTIAGO, EMILIO.

The optimal ethanol lock therapy regimen for treatment of biofilm-associated catheter infections: an in-vitro study

Journal of Hospital Infection. 2018; 100(3): 187-195 Nº de citas: 13 [doi:10.1016/j.jhin.2018.04.007]

Valerio, M; Vena, A; Rodriguez-Gonzalez, CG; de Vega, EC; Mateos, M; Sanjurjo, M; Bouza, E; Munoz, P.

Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(10): 1993-2000 Nº de citas: 18 [doi:10.1007/s10096-018-3335-2]

Fernandez-Cruz, A; Magira, E; Heo, ST; Evans, S; Tarrand, J; Kontoyiannis, DP.

Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes

JOURNAL OF CLINICAL MICROBIOLOGY. 2018; 56(10): Nº de citas: 9 [doi:10.1128/JCM.00962-18]

Munoz, P; Valerio, M; Vasquez, V; Velasquez-Rodriguez, J; Sousa, I; Zatarain, E; Barrio, JM; Ruiz, M; Cuerpo, G; Rodriguez-Abella, H; Hortal, J; Bouza, E; Grp Apoyo Manejo Asistencias Ventr.

Infections in patients after Berlin Heart((R)) EXCOR assist device implantation

Transplant Infectious Disease. 2018; 20(5): Nº de citas: 9 [doi:10.1111/tid.12936]

De Viedma, DG; Perez-Lago, L.

The Evolution of Genotyping Strategies To Detect, Analyze, and Control Transmission of Tuberculosis

Microbiology Spectrum. 2018; 6(5): Nº de citas: 11 [doi:10.1128/microbiolspec.MTBP-0002-2016]

Reigadas, E; Olmedo, M; Valerio, M; Vazquez-Cuesta, S; Alcala, L; Marin, M; Munoz, P; Bouza, E.

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results

Revista Espanola de Quimioterapia. 2018; 31(5): 411-418 Nº de citas: 12

Bordallo-Cardona, MA; Escribano, P; Marcos-Zambrano, LJ; Diaz-Garcia, J; G Gomez de la Pedrosa, Elia; Canton, R; Bouza, E; Guinea, J.

Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

MEDICAL MYCOLOGY. 2018; 56(7): 903-906 Nº de citas: 14 [doi:10.1093/mmy/myx124]

Muñoz P; Agnelli, C; Guinea, J; Vena, A; Alvarez-Uria, A; Marcos-Zambrano, LJ; Escribano, P; Valerio, M; Bouza, E.

Is biofilm production a prognostic marker in adults with candidaemia?

CLINICAL MICROBIOLOGY AND INFECTION. 2018; 24(9): 1010-1015 Nº de citas: 19 [doi:10.1016/j.cmi.2018.01.022]

Stargardt, T; Eckmann, C; Bouza, E; Rossolini, GM; Grossi, PA.

Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2018; 37(9): 1611-1618 Nº de citas: 5 [doi:10.1007/s10096-018-3264-0]